コンテンツへスキップ
Merck
  • Concurrent speed endurance and resistance training improves performance, running economy, and muscle NHE1 in moderately trained runners.

Concurrent speed endurance and resistance training improves performance, running economy, and muscle NHE1 in moderately trained runners.

Journal of applied physiology (Bethesda, Md. : 1985) (2014-09-06)
Casper Skovgaard, Peter M Christensen, Sonni Larsen, Thomas Rostgaard Andersen, Martin Thomassen, Jens Bangsbo
要旨

The purpose of this study was to examine whether speed endurance training (SET, repeated 30-s sprints) and heavy resistance training (HRT, 80-90% of 1 repetition maximum) performed in succession are compatible and lead to performance improvements in moderately trained endurance runners. For an 8-wk intervention period (INT) 23 male runners [maximum oxygen uptake (V̇O(2max)) 59 ± 1 ml·min(-1)·kg(-1); values are means ± SE] either maintained their training (CON, n = 11) or performed high-intensity concurrent training (HICT, n = 12) consisting of two weekly sessions of SET followed by HRT and two weekly sessions of aerobic training with an average reduction in running distance of 42%. After 4 wk of HICT, performance was improved (P < 0.05) in a 10-km run (42:30 ± 1:07 vs. 44:11 ± 1:08 min:s) with no further improvement during the last 4 wk. Performance in a 1,500-m run (5:10 ± 0:05 vs. 5:27 ± 0:08 min:s) and in the Yo-Yo IR2 test (706 ± 97 vs. 491 ± 65 m) improved (P < 0.001) only following 8 wk of INT. In HICT, running economy (189 ± 4 vs. 195 ± 4 ml·kg(-1)·km(-1)), muscle content of NHE1 (35%) and dynamic muscle strength was augmented (P < 0.01) after compared with before INT, whereas V̇O(2max), muscle morphology, capillarization, content of muscle Na(+)/K(+) pump subunits, and MCT4 were unaltered. No changes were observed in CON. The present study demonstrates that SET and HRT, when performed in succession, lead to improvements in both short- and long-term running performance together with improved running economy as well as increased dynamic muscle strength and capacity for muscular H(+) transport in moderately trained endurance runners.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
リン酸カリウム 一塩基性, ACS reagent, ≥99.0%
Sigma-Aldrich
リン酸カリウム 二塩基性, ACS reagent, ≥98%
Sigma-Aldrich
リン酸カリウム 一塩基性, powder, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
リン酸カリウム 一塩基性, buffer substance, anhydrous, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.5-100.5%
Sigma-Aldrich
リン酸カリウム 二塩基性, puriss. p.a., ACS reagent, anhydrous, ≥99.0% (T)
Sigma-Aldrich
リン酸カリウム 一塩基性, for molecular biology, ≥98.0%
Sigma-Aldrich
リン酸カリウム 一塩基性, meets analytical specification of Ph. Eur., NF, E340, anhydrous, 98-100.5% (calc. to the dried substance)
Sigma-Aldrich
リン酸カリウム 二塩基性, anhydrous, for luminescence, for molecular biology, BioUltra, ≥99.0% (T)
Sigma-Aldrich
リン酸カリウム 二塩基性 溶液, 1.0 M
Sigma-Aldrich
リン酸カリウム 一塩基性, ReagentPlus®
Sigma-Aldrich
モノクロナール抗ミオシン(骨格筋, 遅筋型) マウス宿主抗体, clone NOQ7.5.4D, ascites fluid
Sigma-Aldrich
リン酸カリウム 二塩基性, reagent grade, ≥98.0%
Sigma-Aldrich
リン酸カリウム 一塩基性, BioUltra, for molecular biology, anhydrous, ≥99.5% (T)
Sigma-Aldrich
リン酸カリウム 一塩基性, 99.99% trace metals basis
Sigma-Aldrich
抗Na+/K+ ATPase α-1抗体、クローンC464.6, clone C464.6, Upstate®, from mouse
Sigma-Aldrich
リン酸カリウム 二塩基性, 99.95% trace metals basis
Sigma-Aldrich
リン酸カリウム 一塩基性, JIS special grade, ≥99.0%
USP
一塩基性リン酸カリウム, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Potassium phosphate dibasic, meets USP testing specifications
Supelco
リン酸カリウム 一塩基性, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
リン酸カリウム 一塩基性, tested according to Ph. Eur., anhydrous
Sigma-Aldrich
抗Na+K+ ATPase α-2抗体, serum, Upstate®
Sigma-Aldrich
リン酸カリウム 一塩基性, SAJ first grade, ≥99.0%
Sigma-Aldrich
リン酸カリウム 二塩基性, JIS special grade, ≥99.0%
Sigma-Aldrich
抗Na+/H+交換輸送体1抗体、CT、クローン4E9, clone 4E9, Chemicon®, from mouse
Sigma-Aldrich
抗モノカルボン酸トランスポーター4抗体, Chemicon®, from rabbit
Sigma-Aldrich
リン酸カリウム 一塩基性, ≥99.5%
Sigma-Aldrich
リン酸カリウム 二塩基性, SAJ first grade, ≥98.0%